Tursi, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 457
EU - Europa 429
AS - Asia 369
SA - Sud America 129
AF - Africa 10
Totale 1.394
Nazione #
US - Stati Uniti d'America 436
SG - Singapore 158
CN - Cina 107
IT - Italia 107
BR - Brasile 106
DE - Germania 78
SE - Svezia 59
FR - Francia 53
IE - Irlanda 29
GB - Regno Unito 27
ID - Indonesia 23
FI - Finlandia 22
KR - Corea 22
CA - Canada 15
UA - Ucraina 14
IN - India 13
VN - Vietnam 10
CO - Colombia 8
RU - Federazione Russa 7
BD - Bangladesh 6
BE - Belgio 6
PL - Polonia 6
AR - Argentina 5
EC - Ecuador 5
HK - Hong Kong 5
AT - Austria 4
CZ - Repubblica Ceca 4
ES - Italia 4
TR - Turchia 4
JP - Giappone 3
NL - Olanda 3
PK - Pakistan 3
UZ - Uzbekistan 3
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
LT - Lituania 2
MX - Messico 2
SA - Arabia Saudita 2
UY - Uruguay 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
JM - Giamaica 1
KE - Kenya 1
LI - Liechtenstein 1
MA - Marocco 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 1.394
Città #
Chandler 97
Singapore 83
Ashburn 37
Hefei 29
Beijing 27
Dublin 27
New York 26
Milan 24
Frankfurt am Main 23
Munich 23
Jakarta 22
Seoul 22
Los Angeles 16
Rome 14
Helsinki 13
Marseille 13
The Dalles 10
Nuremberg 9
Bogotá 8
Boston 8
Jacksonville 7
Paris 7
Princeton 7
Pune 7
Boardman 6
Brussels 6
Houston 6
North Bergen 6
Brooklyn 5
Fairfield 5
Hong Kong 5
Montreal 5
Portsmouth 5
Seattle 5
São Paulo 5
Toronto 5
Turku 5
Appignano 4
Madrid 4
Moscow 4
Redwood City 4
Wilmington 4
Ann Arbor 3
Belo Horizonte 3
Campinas 3
Caxias do Sul 3
Chelsea 3
Chicago 3
Düsseldorf 3
Florence 3
Hyderabad 3
Lauterbourg 3
London 3
Monte Argentario 3
San Diego 3
San Francisco 3
San Mateo 3
Stockholm 3
Verona 3
Warsaw 3
Washington 3
Baghdad 2
Bexley 2
Bremen 2
Brno 2
Buffalo 2
Busto Arsizio 2
Campo Grande 2
Cattolica 2
Changsha 2
Curitiba 2
Dhaka 2
Edinburgh 2
Falkenstein 2
Guarulhos 2
Guayaquil 2
Hangzhou 2
Hanoi 2
Istanbul 2
Jiaxing 2
Lahore 2
Las Vegas 2
Lawrence 2
Manaus 2
Manchester 2
Mason Vicentino 2
Minneapolis 2
Montevideo 2
Nanjing 2
Naples 2
Ospitaletto 2
Palhoça 2
Pescara 2
Philadelphia 2
Porto Alegre 2
Quito 2
Ribeirão Preto 2
Rio de Janeiro 2
Saint-Fons 2
Salvador 2
Totale 783
Nome #
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 110
Effect of moderate and heavy alcohol consumption on intestinal transit time 107
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. 99
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 83
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease 81
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 81
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 66
Intestinal Microbiome Modulation During Coronavirus Disease 2019: Another Chance to Manage the Disease? 63
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 61
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 57
Microbiota Composition in Diverticular Disease: Implications for Therapy 53
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 53
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 52
Microbiota Composition in Diverticular Disease: Implications for Therapy 48
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 48
Response to Jackson et al 47
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 41
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 37
Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 37
Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis 35
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease 33
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 32
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease 31
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 29
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 23
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study 18
Totale 1.425
Categoria #
all - tutte 8.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 2 7 3 3 1 1 0 2 0 3 1
2021/202281 3 2 0 0 1 1 2 4 3 18 23 24
2022/2023237 27 27 11 40 13 25 16 26 19 10 16 7
2023/2024235 9 43 23 17 8 31 21 4 18 22 28 11
2024/2025557 13 10 45 20 46 13 21 19 46 77 139 108
2025/2026220 201 19 0 0 0 0 0 0 0 0 0 0
Totale 1.425